Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
12-week oral niacin in stable coronary artery disease
2005-005347-25Phase 4Active
- Sponsor
- II. Medizinische Klinik, Universitätsmedizin Mainz
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in coronary arteriosclerosis comparing Niacin plus standard CAD medication with Placebo plus standard CAD medication (2 arms). Primary endpoint: Absolute change in flow-mediated vasodilation. Started Jan 2006; status: active.
02
Drugs
niacin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2005-005347-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005347-25.